Skip to content

Odds of U.S. recession in 12 months are ‘uncomfortably high’ warns Moody’s economist

Odds of U.S. recession in 12 months are ‘uncomfortably high’ warns Moody’s economist
Paul L.
Finance

The likelihood of a U.S. recession within the next year has risen to an “uncomfortably high” level, according to Moody’s Analytics.

The firm’s latest machine learning-based economic indicator places the probability of a downturn at 48% as of August, based on data shared by Moody’s chief economist Mark Zandi on September 14.

Zandi noted that while the figure remains just below the 50% recession threshold, it is significant given historical patterns. 

In past decades, whenever probabilities have approached or surpassed this level, economic contractions have often followed. Since the 1960s, every spike above the mid-40% range has coincided with or preceded a recession, as reflected in shaded periods on economic charts.

Zandi’s past economic warnings 

The current probability aligns with Zandi’s earlier warnings, in which he argued that several U.S. states, representing nearly one-third of national GDP, are either already in recession or at high risk of entering one. 

Another third are “treading water,” while the remainder are growing, though often weakly. Key sectors under strain include manufacturing, construction, and transportation, while job growth has slowed sharply.

Zandi has also cited trade policy and immigration restrictions as intensifying headwinds. Tariffs, reduced government funding, and falling labor force participation, particularly among immigrants, are among the factors he believes could tip the balance.

He has placed particular emphasis on employment data: job gains have been smaller than expected, unemployment has edged higher, and revisions to earlier reports have revealed weaker performance than initially estimated.

While Zandi does not believe the U.S. is currently in a technical recession, he describes the economy as being “on the precipice.”

Featured image via Shutterstock

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Finance

Finbold AI Agent

How AI Price Predictions Work

We use cutting-edge AI models to forecast future prices for stocks and crypto.

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.